• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.51% Nasdaq Up 1.26%

    ArQule Inc. (ARQL)

    -NasdaqGM
    1.66 0.00(0.00%) 12:25PM EST - Nasdaq Real Time Price
    Prev Close:1.66
    Open:1.68
    Bid:1.65 x 100
    Ask:1.68 x 600
    1y Target Est:4.00
    Beta:1.88458
    Earnings Date:Mar 2 - Mar 7 (Est.)
    Day's Range:1.65 - 1.69
    52wk Range:1.30 - 2.65
    Volume:10,926
    Avg Vol (3m):96,682
    Market Cap:104.40M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARQL

    Comparison

    Symbol% ChgMkt Cap
    ARQL 0.00%104.40M
    ARRYDown 0.39%362.25M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.23
    Quarterly EPS Est (Dec-15) :-0.06
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-1.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ArQule, Inc., a clinical-stage biotechnology company, researches and develops therapeutics for the treatment of cancer and rare diseases. Its lead product candidate is tivantinib, a small molecule inhibitor of the c-Met receptor tyrosine kinase an... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback